Sharma Ashish, Chaturvedi Rajeev, Sharma Arun, Sorrell James H
Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68198-8470, USA.
J ECT. 2009 Jun;25(2):141-3. doi: 10.1097/YCT.0b013e31817e8ab4.
Numerous studies have demonstrated the safety and efficacy of electroconvulsive therapy (ECT) for various psychiatric conditions, and it has been approved by the Food and Drug Administration for the treatment of refractory depression. Recently, the Food and Drug Administration also approved vagus nerve stimulation as a treatment for chronic or recurrent depression. Although electrical stimulation is used for both ECT and vagus nerve stimulation, the mechanisms of their action are very different. The American Psychiatric Association task force identifies no absolute contraindications to the use of ECT. The authors present 2 interesting cases of successful ECT in combination with vagus nerve stimulator.
大量研究已证明电休克疗法（ECT）对各种精神疾病的安全性和有效性，并且它已获得美国食品药品监督管理局批准用于治疗难治性抑郁症。最近，美国食品药品监督管理局还批准了迷走神经刺激术用于治疗慢性或复发性抑郁症。虽然ECT和迷走神经刺激术都使用电刺激，但它们的作用机制非常不同。美国精神病学协会特别工作组确定ECT的使用不存在绝对禁忌症。作者介绍了2例成功将ECT与迷走神经刺激器联合使用的有趣病例。
